A subpopulation of CD24+ cells in colon cancer cell lines possess stem cell characteristics

Neoplasma

Volumn 59, Issue 3, 2012, Pages 282-288

  Ke, J ^a   Wu, X ^a,a   He, X ^a   Lian, L ^a   Zou, Y ^a   Wang, H ^a   Luo, Y ^a   Wang, L ^a   Lan, P ^a  

^a THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cancer stem cell; CD24; Colon cancer; Self renewal; Stem cell marker

Indexed keywords

CD133 ANTIGEN; CD24 ANTIGEN; HERMES ANTIGEN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; OXALIPLATIN; PLATINUM COMPLEX; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENICITY; CELL PROLIFERATION; CELL RENEWAL; CELL SELECTION; CELL SUBPOPULATION; CHEMOTHERAPY; CLONOGENESIS; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; ANIMAL; COLON TUMOR; DRUG RESISTANCE; FEMALE; METABOLISM; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; TRANSPLANTATION; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD24; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; ORGANOPLATINUM COMPOUNDS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863843869     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2012_036     Document Type: Article

References (19)

1. CLEVERS HT. The cancer stem cell: premises, promises and challenges. Nat Med 2011; 17: 313-319. http://dx.doi.org/10.1038/nm.2304
2. SOLTYSOVA A, ALTANEROVA V, ALTANER C. Cancer stem cells. Neoplasma. 2005; 52: 435-440.
3. HUNAKOVA L, SEDLAKOVA O, CHOLUJOVA D, GRONESOVA P, DURAJ J et al. Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane. Neoplasma. 2009; 56: 548-556. http://dx.doi.org/10.4149/neo_2009_06_548
4. FUKUDA K, SAIKAWA Y, OHASHI M, KUMAGAI K, KITAJIMA M, et al. Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol 2009; 34: 1201-1207.
5. CUI F, WANG J, CHEN D, CHEN YJ. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer. Oncol Rep 2009; 21: 995-1000.
6. WANG YH, LI F, LUO B, WANG XH, SUN HC et al. A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Neoplasma 2009; 56: 371-378. http://dx.doi.org/10.4149/neo_2009_05_371
7. QIAO B, JOHNSON NW, CHEN X, LI R, TAO Q, et al. Disclosure of a stem cell phenotype in an oral squamous cell carcinomacell line induced by BMP-4 via an epithelial-mesenchymal transition. Oncol Rep 2011; 26: 455-461.
8. KONG DS, KIM MH, PARK WY, SUH YL, LEE JI, et al: The progression of gliomas is associated with cancer stem cell phenotype. Oncol Rep 22: 1129-1134, 2009.
9. AL-HAJJ M, WICHA MS, BENITO-HERNANDEZ A, MORRISON SJ, CLARKE MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-3988. http://dx.doi.org/10.1073/pnas.0530291100
10. VITIANI LR, LOMBARDI DG, PILOZZI E, BIFFONI M, TODARO M, et al. Identification and expansion of human colon-cancerinitiating cells. Nature 2007; 445: 111-115. http://dx.doi.org/10.1038/nature05384
11. O'BRIEN CA, POLLETT A, GALLINGER S, DICK JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110.
12. SHMELKOV SV, BUTLER JM, HOOPER AT, HORMIGO A, KUSHNER J, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors. J Clin Invest 2007; 118: 2111-2120.
13. DALERBA P, DYLLA SJ, PARK IK, LIU R, WANG X, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 2007; 104: 10158-101563. http://dx.doi.org/10.1073/pnas.0703478104
14. MERLOS-SUAREZ A, BARRIGA FM, JUNG P, IGLESIAS M, CESPEDES MV, et al. The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse. Cell Stem Cell 2011; 8: 511-524. http://dx.doi.org/10.1016/j.stem.2011.02.020
15. AIGNER S, RUPPERT M, HUBBE M, SAMMAR M, STHOEGER Z, et al. Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin. Int Immunol 1995; 7: 1557-1565. http://dx.doi.org/10.1093/intimm/7.10.1557
16. AIGNER S, STHOEGER Z. M, FOGEL M, WEBER E, ZARN J, et al. CD24, a mucin-type glycoprotein, is a ligand for Pselectin on human tumor cells. Blood 1997; 89: 3385-3395.
17. CHOI D, LEE HW, HUR KY, KIM JJ, PARK GS, et al. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J Gastroenterol 2009; 15: 2258-2264. http://dx.doi.org/10.3748/wjg.15.2258
18. WEICHERT W, DENKERT C, BURKHARDT M, GANSUKH T, BELLACH J, et al. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 2005; 11: 6574-6581. http://dx.doi.org/10.1158/1078-0432.CCR-05-0606
19. SAGIV E, MEMEO L, KARIN A, KAZANOV D, JACOBHIRSCH J, et al. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 2006; 131: 630-639. http://dx.doi.org/10.1053/j.gastro.2006.04.028